| Detailed information |
|---|
| CancerLivER ID | 2245 |
| Biomarker | RP11-160H22.5, XLOC_014172, LOC149086 |
| Biomarker Name/Symbol (given in Publication) | RP11-160H22.5, XLOC_014172 and LOC149086 |
| Biomolecule | LncRNA |
| Subject | Human |
| Degree of Validity | Biomarker for the tumorigenesis prediction and for metastasis prediction and validated on independent dataset |
| Experimental Condition | HCC v/s Normal; associated with metastatsis of patients |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Upregulated in HCC with Fold change >2.0 |
| Level of significance | p < 0.01 |
| Source | Plasma |
| PMID | 25714016 |
| Type of Biomarker | Diagnostic and Prognostic |
| Pathway | NA |
| Cohort | 467 patients: 217 HCC, 250 control, 100 CH (chronic hepatitis); Training dataset: 20 cases and 20 controls; Validation dataset:147 cases and 180 controls |
| Sensitivity | 82% |
| Specificity | 73% |
| Accuracy | NA |
| AUC | 0.896 |
| Disease | Human HCC |
| Year of Publication | 2015 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |